CClinicalTrials.gg
CompletedNCT03293355Updated Jul 23, 2020

Multilevel Integration Strategies to Enhance Service Provider Networks in Vietnam

An interventional study of VPN in Linkage to Care, sponsored by University of California, Los Angeles. Completed at 4 sites in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-23.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
320
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

There is an urgent need for treatment service integration for People Living with HIV (PLH) because many PLH have comorbid conditions, including substance use disorders and psychiatric disorders, among others. Although providing integrated services to PLH who use drugs (PLHWUD) has been proven to produce positive outcomes, multilevel challenges must be addressed, including barriers at the policy, structural, and provider levels. Many countries, including Vietnam, face challenges in the pursuit of multilevel integration of combination treatment services and care. In Vietnam, injecting drug use accounts for nearly two-thirds of HIV infection, and methadone maintenance therapy (MMT) services have rapidly expanded to 135 clinics with over 25,000 clients since 2008. There is a timely call as well as an opportunity to identify, implement and evaluate new strategies to provide MMT and HIV treatment as an integrated service system for PLHWUD. The study will take advantage of this window of opportunity to explore and pilot integration strategies to address the multilevel challenges associated with service integration in Vietnam.

Read the detailed description

The purpose of this study is to develop and pilot test intervention strategies at the provincial level (Aim 1), treatment agency level (Aim2), and community level (Aim 3). These strategies aim to strengthen both horizontal and vertical collaboration and networking among providers to better serve people living with HIV who use drugs (PLHWUD), including those who are already in treatment and those who need to be linked to service. Commune health workers (CHW) have great potentials to be mobilized to engage PLHWUD living in the community and to work with providers at treatment clinics to support PLHWUD treatment retention and adherence. E-technologies such as Facebook and e-chat will also be utilized to enhance provider-provider coordination and provider-patient interaction.

The Specific Aims of the study are as follows:

Aim 1: Develop and implement structural-level strategies by establishing a provincial coordination team to improve coordination and service integration.

Aim 2: Assess agency-level intervention outcomes on treatment-provider collaboration and service integration of OPC services and MMT programs.

Aim 3: Assess community provider-level intervention outcomes by evaluating whether: 1) CHW in the intervention group, compared to those in the control group, demonstrate improved levels of collaboration with other clinical agencies, communication with patients, and service referrals, and 2) PLHWUD in the intervention group, compared to those in the control group, demonstrate improvements in treatment initiation, retention and adherence, and other mental and biological outcomes.

Based on the findings from Aims 1 and 2 activities, this intervention will be conducted in four provinces of Vietnam(Bac Giang, Hai Duong, Nam Dinh, and Nghe An). Randomization will occur at the community level (20 communes assigned to the intervention group; 20 communes assigned to the control group).

CONTROL COMMUNE ACTIVITIES:

A total of 40 CHW from 20 communes assigned to the control group will be invited to participate in a one-time didactic lecture/meeting with other co-workers from their commune health centers to learn about the importance of service integration.

CHW(n=40) and PLHWUD(n=120) from the control commune health centers will participate in a baseline assessment and follow-up assessments at 3, 6, 9, 12-months.

INTERVENTION COMMUNE ACTIVITIES:

A total of 40 CHW from 20 communes assigned to the intervention group will be invited to participate in the intervention that will consist of two in-person sessions lasting approximately 90 minutes over two weeks with 8-10 CHW in each session.

Booster sessions of the intervention training will be offered to CHW once every month during the first three months and once every three months thereafter. The booster session will focus on CHW' reports of their experiences, reinforcement of efforts, and continued skill building for problem solving. CHW(n=40) and PLHWUD(n=120) from the intervention commune health centers will participate in a baseline assessment and follow-up assessments at 3, 6, 9, 12-months.

The efficacy of the intervention will be assessed at baseline, 3, 6, 9, and 12-month follow-ups.

02

Conditions studied

  • Linkage to Care

Keywords

  • People Living with HIV Who Use Drugs (PLHWUD)
  • Community Health Workers (CHW)
  • Multilevel Service Integration
  • HIV/AIDS
  • Vietnam
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

CHW:

  • Age 18 or over
  • Be a service provider to PLHWUD attending commune health centers in one of the 40 communes selected selected for the study
  • Voluntary written informed consent

PLHWUD:

  • Age 18 or over
  • HIV positive (self-report)
  • Currently using opiates or has a history of opiate use (self-report) and seeking services at the commune health centers in one of 40 communes selected from the study
  • Has not received treatment services from OPC or MMT clinics (i.e., is treatment naive).
  • Voluntary written informed consent

Exclusion criteria

Exclusion Criteria:

CHW:

  • Inability to give informed consent

PLHWUD:

  • Inability to give informed consent
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
320 participants (actual)

Study arms

  • No intervention
    Control

    Standard of care

  • Experimental
    Intervention

    The VPN intervention has 2 in-person sessions: 1) Providing training on service integration and team building for CHW and tools for them to network more effectively with OPC and MMT treatment providers as well as reach out to their patients; and 2) Learning to use effective communication tools such as motivational ruler and decision balance sheet to work more effectively with their patients and use Facebook group to facilitate collaboration among providers and e-chat for patient engagements. Sessions will occur once a week for two weeks, with each session featuring a different set of themes and relevant activities.

    Behavioral: VPN

Interventions

  • BehavioralVPN

    Two in-person sessions will take place one week apart for the VPN intervention targeting CHW. The intervention contents aim to utilize traditional communications tools and the latest technology to tackle challenges faced by service providers working in commune health centers and the impact of these challenges on their patients' treatment initiation, retention, and adherence. In addition, booster sessions will be offered once every month during the first three months and once every three months thereafter. The booster sessions will focus on participants' reports of their experiences, reinforcement of efforts, and continued skill building for problem solving.

05

What researchers measure

Primary outcomes

  1. PLHWUD's service utilization

    This will be measured by PLHWUD's utilization of health services including OPC and MMT. Both their access and adherence to treatments will be assessed.

    Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups

  2. CHW interaction with providers of other treatment agencies

    This will be measured by a multi-item scale on interaction with other treatment providers

    Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups

Secondary outcomes

  1. PLHWUD's service satisfaction

    PLHWUD's service satisfaction will be measured using a 12-item scale to evaluate patients' service satisfaction with MMT and OPC treatment based on the Texas Christian University Client Evaluation of Self and Treatment (TCU-CEST) forms.

    Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups

  2. CHW's patient-provider interaction with PLHWUD

    CHW's communication and interaction with PLHWUD will be measured by a self-reported scale and the provider-patient communication logs.

    Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups

  3. CHW's service provision

    Service provision such as patient referrals will be captured by the reported frequency and type of service referrals made in the past three months to other treatment clinics will also be documented.

    Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups

06

Study locations

4 sites
  • Commune Health Centers
    Thành Phố Hải Dương, Hải Dương, Vietnam
  • Commune Health Centers
    Nghi An, Nghe An, Vietnam
  • Commune Health Centers
    Bắc Giang, Vietnam
  • Commune Health Centers
    Nam Định, Vietnam
07

Registry details

Key details

Study ID
NCT03293355
Lead sponsor
University of California, Los Angeles
Collaborators
National Institute of Hygiene and Epidemiology, Vietnam
Responsible party
Li Li (Professor in Residence, University of California, Los Angeles) — Principal investigator
First posted
Sep 26, 2017
Start date
Mar 1, 2018
Primary completion
May 31, 2020
Completion
May 31, 2020
Last update
Jul 23, 2020

Study contacts

Li Li, PhD
principal investigator · University of California, Los Angeles

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion